Cargando…

Changes of Gene Expressions in Spontaneously Hypertensive Rat Model After Losartan Treatment

BACKGROUND AND OBJECTIVES: The renin angiotensin system seems to play an important role in the development of cardiac and vascular hypertrophy in hypertension. The changes in pathology, and gene expressions of the angiotensin II receptor type 1A (ATIA) and angiotensin converting enzyme (ACE) were in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cha, Ji Hei, Lee, Hye Ryon, Kim, Kwan Chang, Cho, Min-Sun, Hong, Young Mi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518710/ https://www.ncbi.nlm.nih.gov/pubmed/23236328 http://dx.doi.org/10.4070/kcj.2012.42.11.761

Ejemplares similares

Changes of Bax, Bcl-2, CCR-2, MCP-1, and TGF-β1 genes in the left ventricle of spontaneously hypertensive rat after losartan treatment
por: Lee, Hyeryon, et al.
Publicado: (2019)

Changes of blood pressure, abdominal visceral fat tissue and gene expressions in fetal programming induced rat model after amlodipine–losartan combination treatment
por: Lee, Ji Hyen, et al.
Publicado: (2016)

Losartan Reduces Remodeling and Apoptosis in an Adriamycin-Induced Cardiomyopathy Rat Model
por: Kim, Hyeon A, et al.
Publicado: (2023)

Effects of Losartan, Atorvastatin, and Aspirin on Blood Pressure and Gut Microbiota in Spontaneously Hypertensive Rats
por: Dong, Shuai, et al.
Publicado: (2023)

Influence of losartan and enalapril on the diclofenac effect on leukocyte–endothelium interaction in spontaneously hypertensive rats (SHR)
por: Martinez, LL, et al.
Publicado: (2003)

Changes of Pulmonary Pathology and Gene Expressions After Simvastatin Treatment in the Monocrotaline-Induced Pulmonary Hypertension Rat Model
por: Lee, Yun Hee, et al.
Publicado: (2011)

Long-term prehypertension treatment with losartan effectively prevents brain damage and stroke in stroke-prone spontaneously hypertensive rats
por: HE, DE-HUA, et al.
Publicado: (2014)

Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats
por: Klimas, Jan, et al.
Publicado: (2015)

Changes of Gene Expression after Bone Marrow Cell Transfusion in Rats with Monocrotaline-Induced Pulmonary Hypertension
por: Kim, Kwan Chang, et al.
Publicado: (2012)

Effects of Antihypertensive Agents on Intestinal Contractility in the Spontaneously Hypertensive Rat: Angiotensin Receptor System Downregulation by Losartan
por: Patten, Glen Stephen, et al.
Publicado: (2017)

Effects of Long-Term Intervention with Losartan, Aspirin and Atorvastatin on Vascular Remodeling in Juvenile Spontaneously Hypertensive Rats
por: Liu, Qi, et al.
Publicado: (2023)

Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
por: Mulinari-Santos, Gabriel, et al.
Publicado: (2019)

Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats.
por: Park, C. G., et al.
Publicado: (2001)

Effects of Captopril and Losartan on Cardiac Stereology in Rats with Renovascular Hypertension
por: Akbar Nekooeian, Ali, et al.
Publicado: (2021)

Losartan Attenuates Myocardial Endothelial-To-Mesenchymal Transition in Spontaneous Hypertensive Rats via Inhibiting TGF-β/Smad Signaling
por: Wu, Miao, et al.
Publicado: (2016)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

Change of voltage-gated potassium channel 1.7 expressions in monocrotaline-induced pulmonary arterial hypertension rat model
por: Lee, Hyeryon, et al.
Publicado: (2018)

Expression and Change of miRs 145, 221 and 222 in Hypertensive Subjects Treated with Enalapril, Losartan or Olmesartan
por: Mandraffino, Giuseppe, et al.
Publicado: (2021)

Effects of Spironolactone and Losartan on Diabetic Nephropathy in a Type 2 Diabetic Rat Model
por: Lee, Mi Young, et al.
Publicado: (2011)

Effects of Single and Combined Losartan and Tempol Treatments on Oxidative Stress, Kidney Structure and Function in Spontaneously Hypertensive Rats with Early Course of Proteinuric Nephropathy
por: Karanovic, Danijela, et al.
Publicado: (2016)

Effect of prehypertensive losartan therapy on AT1R and ATRAP methylation of adipose tissue in the later life of high-fat-fed spontaneously hypertensive rats
por: Wang, Tingjun, et al.
Publicado: (2018)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
por: Keković, Goran, et al.
Publicado: (2012)

Gene Expression of Endothelin-1 and Endothelin Receptor A on Monocrotaline-Induced Pulmonary Hypertension in Rats After Bosentan Treatment
por: Lim, Kyoung Ah, et al.
Publicado: (2010)

Electroacupuncture Delays Hypertension Development through Enhancing NO/NOS Activity in Spontaneously Hypertensive Rats
por: Hwang, Hye Suk, et al.
Publicado: (2011)

Clusterin is highly expressed in tubular complexes during spontaneous pancreatitis of spontaneous hypertensive rats
por: PARK, Jun Won, et al.
Publicado: (2018)

Apoptosis and Inflammation Associated Gene Expressions in Monocrotaline-Induced Pulmonary Hypertensive Rats after Bosentan Treatment
por: Hong, Young Mi, et al.
Publicado: (2014)

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
por: Vitale, Cristiana, et al.
Publicado: (2005)

Health-care costs of losartan and candesartan in the primary treatment of hypertension
por: Henriksson, M, et al.
Publicado: (2011)

Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
por: Bharati, Sandesh Madhukar, et al.
Publicado: (2016)

Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
por: Rakesh, K. B., et al.
Publicado: (2016)

The impact of an URAT1 polymorphism on the losartan treatment of hypertension and hyperuricemia
por: Wu, Liting, et al.
Publicado: (2021)

Does Losartan reduce the severity of COVID-19 in hypertensive patients?
por: Mirjalili, Mohammadreza, et al.
Publicado: (2022)

An inhibitory effect of tumor necrosis factor-alpha antagonist to gene expression in monocrotaline-induced pulmonary hypertensive rats model
por: Kwon, Jung Hyun, et al.
Publicado: (2013)

Gene Expressions of Nitric Oxide Synthase and Matrix Metalloproteinase-2 in Monocrotaline-Induced Pulmonary Hypertension in Rats After Bosentan Treatment
por: Koo, Hee Sun, et al.
Publicado: (2011)

Losartan/Hydrochlorothiazide Fixed Combination Versus Amlodipine Monotherapy in Korean Patients With Mild to Moderate Hypertension
por: Chung, Jin-Wook, et al.
Publicado: (2009)

Nephroprotective effect of losartan in IgA model rat
por: Xing, Li, et al.
Publicado: (2019)

Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
por: Morrell, Nicholas W, et al.
Publicado: (2005)

Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension
por: Granström, Ola, et al.
Publicado: (2012)

Cerebrovascular gene expression in spontaneously hypertensive rats
por: Grell, Anne-Sofie, et al.
Publicado: (2017)

Antihypertensive and antihyperglycemic effects of combinations of losartan with metformin and/or glibenclamide in desoxycorticosterone acetate and streptozotocin-induced hypertensive diabetic rats
por: Moke, Emuesiri Goodies, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lft9mjl8khpq5kqjr3j384q28b